Comparison of the bis‐intercalating complexes formed between either ditercalinium or a flexible analogue and d(CpGpCpG)2 or d(TpTpCpGpCpGpApA)2 minihelices: 1H‐ and 31P‐nmr analyses

The 400‐MHz 1H‐ and 162‐MHz 31F‐nmr have been used to study complexes constituted by (a) the d(TpTpCpGpCpGpApA)2 or the d(CpGpCpG)2 self‐complementary oligonucleotides and (b) two bifunctional 7H‐pyrido [4, 3‐c] carbazole dimer drugs, the antitumoral ditercalinium (NSC 366241), a dimer with a rigid bis‐piperidine linking chain and its pharmacologically inactive analogue, a dimer with a flexible spermine‐like linking chain. Nearly all proton and phosphorus signals have been assigned by two‐dimensional (2D) nmr (correlated spectroscopy, homonuclear Hartmann‐Hahn, nuclear Overhauser enhancement spectroscopy, 2D 31P {1H} heteronuclear correlated spectroscopy and 31P‐31P chemical exchange experiments). Both drugs bis‐intercalate into the two CpG sites. The complexes show small differences in the position of the 7H‐pyrido[4, 3‐c]carbazole ring into the intercalation site and possibly in the ribose‐phosphate backbone deformation. However, the inactive analogue exhibits a longer residence lifetime in octanucleotide than the ditercalinium does. All these results are discussed in terms of differences in dimer activities.

[1]  A. Rich,et al.  Drug-induced DNA repair: X-ray structure of a DNA-ditercalinium complex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  B. Roques,et al.  Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions. , 1990, Anti-cancer drug design.

[3]  S. Brown,et al.  Selective alteration of mitochondrial function by Ditercalinium (NSC 335153), a DNA bisintercalating agent. , 1990, Biochemical pharmacology.

[4]  M. Delepierre,et al.  Bisintercalation of ditercalinium into a d(CpGpApTpCpG)2 minihelix: A 1H‐ and 31P‐NMR study , 1989, Biopolymers.

[5]  M. Delepierre,et al.  Intercalative binding of ditercalinium to d(CpGpCpG)2: a theoretical study. , 1989, Journal of biomolecular structure & dynamics.

[6]  M. Delepierre,et al.  1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers. , 1989, Journal of molecular biology.

[7]  B. Roques,et al.  The noncovalent complex between DNA and the bifunctional intercalator ditercalinium is a substrate for the UvrABC endonuclease of Escherichia coli. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Patel,et al.  Antitumour drug–DNA interactions: NMR studies of echinomycin and chromomycin complexes , 1989, Quarterly Reviews of Biophysics.

[9]  B. Roques,et al.  Acridine dimers: influence of the intercalating ring and of the linking-chain nature on the equilibrium and kinetic DNA-binding parameters. , 1989, European journal of biochemistry.

[10]  M. Delepierre,et al.  1H‐nmr studies of a monointercalating drug into a d[CpGpCpG]2 minihelix , 1987, Biopolymers.

[11]  B. Roques,et al.  Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent. , 1988, Cancer research.

[12]  M. Delepierre,et al.  Study of the bisintercalation of the antitumor drug ditercalinium by 31P‐nmr , 1988, Biopolymers.

[13]  B. Roques,et al.  Asymmetrical bisintercalators as potential antitumor agents. , 1988, Journal of medicinal chemistry.

[14]  B. Roques,et al.  Induction of an abortive and futile DNA repair process in E. coli by the antitumor DNA bifunctional intercalator, ditercalinium: role in polA in death induction. , 1988, Nucleic acids research.

[15]  M. Delepierre,et al.  A general procedure for assigning the 31P spectra of drug-oligonucleotide complexes. , 1988, Journal of biomolecular structure & dynamics.

[16]  B. Reid Sequence-specific assignments and their use in NMR studies of DNA structure , 1987, Quarterly Reviews of Biophysics.

[17]  M. Delepierre,et al.  Bisintercalation of ditercalinium into a d[CpGpCpG]2 minihelix: Structure and dynamics aspects—a 400‐MHz 1H‐nmr study , 1987, Biopolymers.

[18]  M. Delepierre,et al.  DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series. , 1987, Anti-cancer drug design.

[19]  M. Delepierre,et al.  Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Roques,et al.  Synthesis of 11H-pyridocarbazoles and derivatives. Comparison of their DNA binding and antitumor activity with those of 6H- and 7H-pyridocarbazoles. , 1986, Journal of medicinal chemistry.

[21]  Ad Bax,et al.  MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .

[22]  K. Houk,et al.  Transition structures for additions of lithium hydride and methyllithium to ethylene and acetylene , 1985 .

[23]  W. Denny,et al.  Proton NMR study of the binding of bis(acridines) to d(AT)5.cntdot.d(AT)5. 2. Dynamic aspects , 1985 .

[24]  B. Roques,et al.  Effects of new antitumor bifunctional intercalators derived from 7H-pyridocarbazole on sensitive and resistant L 1210 cells. , 1984, Cancer research.

[25]  David G. Gorenstein,et al.  Phosphorus-31 NMR : principles and applications , 1984 .

[26]  K. Wüthrich,et al.  Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.

[27]  Ray Freeman,et al.  Broadband heteronuclear decoupling , 1982 .

[28]  B. Roques,et al.  DNA intercalating compounds as potential antitumor agents. 1. Preparation and properties of 7H-pyridocarbazoles. , 1980, Journal of medicinal chemistry.

[29]  P. Dessen,et al.  Deoxyribonucleic acid bifunctional intercalators: kinetic investigation of the binding of several acridine dimers to deoxyribonucleic acid. , 1979, Biochemistry.

[30]  B. Roques,et al.  DNA bifunctional intercalators: antileukemic activity of new pyridocarbazole dimers. , 1979, Biochemical pharmacology.

[31]  B. Roques,et al.  DNA Bifunctional intercalators. 2. Fluorescence properties and DNA binding interaction of an ethidium homodimer and an acridine ethidium heterodimer. , 1978, Biochemistry.

[32]  B. Roques,et al.  DNA bifunctional intercalators. I. Synthesis and conformational properties of an ethidium homodimer and of an acridine ethidium heterodimer. , 1978, Biochemistry.

[33]  M Le Bret,et al.  DNA polyintercalating drugs: DNA binding of diacridine derivatives. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Le Pecq,et al.  The change of the torsion of the DNA helix caused by intercalation. II. Measurement of the relative change of torsion induced by various intercalating drugs. , 1971, Biochimie.

[35]  H. Eisenberg,et al.  Viscosity and sedimentation study of sonicated DNA–proflavine complexes , 1969 .